Profile data is unavailable for this security.
About the company
Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
- Revenue in JPY (TTM)269.92bn
- Net income in JPY21.44bn
- Incorporated1957
- Employees4.79k
- LocationTowa Pharmaceutical Co Ltd2-11, Shimbashi-choKADOMA-SHI 571-8580JapanJPN
- Phone+81 669009100
- Fax+81 669082138
- Websitehttps://www.towayakuhin.co.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Katakura Industries Co Ltd | 40.98bn | 5.84bn | 110.93bn | 941.00 | 17.28 | 1.10 | 12.61 | 2.71 | 182.30 | 182.30 | 1,278.51 | 2,853.06 | 0.2926 | 2.15 | 6.42 | 43,545,160.00 | 4.27 | 2.60 | 5.20 | 3.57 | 36.16 | 37.98 | 14.59 | 9.44 | 2.63 | -- | 0.0807 | 23.42 | -1.37 | -2.19 | 15.73 | 15.27 | -7.22 | 33.03 |
| Zeria Pharmaceutical Co Ltd | 86.61bn | 7.26bn | 111.08bn | 1.75k | 13.19 | 0.9976 | 7.63 | 1.28 | 164.79 | 164.79 | 1,964.97 | 2,178.21 | 0.5366 | 1.27 | 3.21 | 49,607,640.00 | 4.49 | 4.67 | 6.99 | 7.47 | 72.76 | 72.17 | 8.37 | 9.02 | 0.9739 | 11.41 | 0.2984 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
| Mochida Pharmaceutical Co Ltd | 111.92bn | 6.42bn | 135.19bn | 1.51k | 20.51 | 0.9583 | 14.40 | 1.21 | 181.16 | 181.16 | 3,156.95 | 3,876.77 | 0.6427 | 1.67 | 3.02 | 74,214,190.00 | 3.69 | 4.50 | 4.47 | 5.44 | 48.43 | 52.49 | 5.74 | 6.87 | 2.85 | -- | 0.0678 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
| Kaken Pharmaceutical Co Ltd | 75.66bn | -3.83bn | 186.71bn | 1.13k | -- | 1.10 | -- | 2.47 | -97.11 | -97.11 | 1,980.56 | 3,850.39 | 0.4091 | 1.86 | 2.80 | 67,195,380.00 | -2.07 | 5.99 | -2.42 | 6.87 | 53.09 | 56.17 | -5.06 | 12.91 | 3.21 | -- | 0.0257 | 59.58 | 30.52 | 1.05 | 73.77 | -6.36 | 14.81 | 0.00 |
| Towa Pharmaceutical Co Ltd | 269.92bn | 21.44bn | 210.70bn | 4.79k | 9.39 | 1.06 | 4.84 | 0.7806 | 435.61 | 435.61 | 5,483.17 | 3,853.29 | 0.5695 | 1.49 | 3.37 | 56,374,690.00 | 4.52 | 3.89 | 5.53 | 5.07 | 36.72 | 37.81 | 7.94 | 6.61 | 1.54 | 32.77 | 0.5519 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
| Kissei Pharmaceutical Co Ltd | 95.29bn | 14.14bn | 214.33bn | 1.78k | 13.65 | 0.8821 | 11.35 | 2.25 | 337.47 | 337.47 | 2,274.29 | 5,220.29 | 0.3748 | 1.85 | 2.83 | 53,596,180.00 | 5.62 | 4.26 | 6.19 | 4.60 | 48.21 | 48.59 | 14.99 | 14.30 | 3.42 | -- | 0.0058 | 32.41 | 16.87 | 6.91 | 7.18 | 33.54 | 31.04 | 13.97 |
| Sawai Group Holdings Co Ltd | 200.68bn | -1.25bn | 266.31bn | 3.31k | -- | 1.49 | 18.44 | 1.33 | -9.86 | -22.64 | 1,734.07 | 1,548.25 | 0.5445 | 1.28 | 3.40 | 60,628,400.00 | -0.3389 | -0.2327 | -0.4542 | -0.3187 | 28.89 | 32.95 | -0.6224 | -0.475 | 1.08 | -1.04 | 0.4066 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Tsumura & Co | 189.50bn | 29.01bn | 310.56bn | 4.27k | 10.45 | 0.9878 | 7.28 | 1.64 | 387.15 | 387.15 | 2,524.84 | 4,095.99 | 0.374 | 0.7106 | 2.41 | 44,357,680.00 | 6.01 | 5.53 | 8.06 | 6.85 | 47.60 | 49.39 | 16.06 | 14.50 | 1.45 | -- | 0.2856 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
Data as of Feb 17 2026. Currency figures normalised to Towa Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
19.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 30 Jan 2026 | 2.65m | 5.15% |
| Brown Capital Management LLCas of 30 Sep 2025 | 2.40m | 4.66% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 911.22k | 1.77% |
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 872.70k | 1.69% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 768.89k | 1.49% |
| Guardians of New Zealand Superannuationas of 30 Jun 2025 | 705.29k | 1.37% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 391.90k | 0.76% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 373.20k | 0.72% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 359.60k | 0.70% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 353.00k | 0.69% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
